Secondary hyperpigmentation during interferon Alfa treatment for chronic hepatitis C virus infection

JAMA Dermatology

Volumn 149, Issue 6, 2013, Pages 675-677

  Tsilika, Katerina ^a   Tran, Albert ^a   Trucchi, Régine ^a   Pop, Sinziana ^a   Anty, Rodolphe ^a   Cardot Leccia, Nathalie ^a   Lacour, Jean Philippe ^a   Ortonne, Jean Paul ^a   Passeron, Thierry ^a  

^a UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; AGED; ARTICLE; DEMOGRAPHY; DRUG WITHDRAWAL; EPILUMINESCENCE MICROSCOPY; FEMALE; FRANCE; HEPATITIS C; HUMAN; HYPERPIGMENTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MELANONYCHIA; MOUTH MUCOSA; MUCOSA; NAIL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECONDARY HYPERPIGMENTATION; SKIN; SKIN BIOPSY;

ADULT; AGED; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; HYPERPIGMENTATION; INTERFERON-ALPHA; MALE; MIDDLE AGED; MUCOUS MEMBRANE; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RIBAVIRIN; SKIN PIGMENTATION;

EID: 84879362514     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.1989     Document Type: Article

References (15)

1. Berk DR, Mallory SB, Keeffe EB, Ahmed A. Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy. Clin Gastroenterol Hepatol. 2007;5(2):142-151. (Pubitemid 46216927)
2. Willems M, Munte K, Vrolijk JM, et al. Hyperpigmentation during interferonalpha therapy for chronic hepatitis C virus infection. Br J Dermatol. 2003;149 (2):390-394. (Pubitemid 37100268)
3. Aguayo-Leiva I, Pérez B, Salguero I, Jaén P. Tongue hyperpigmentation during interferon-alpha and ribavirin therapy. Eur J Dermatol. 2009;19(3):291-292.
4. Dag MS, Aydinli M, Kazanci U, Kadayifci A. Facial hyperpigmentation during pegylated interferon alpha therapy for chronic hepatitis B infection. Acta Gastroenterol Belg. 2011;74(1):103-104.
5. de Moraes PC, Noce CW, Thomaz LA, Mautoni MC, Corrêa ME. Tongue hyperpigmentation resulting from peginterferon alfa and ribavirin combination therapy: a case report. J Am Dent Assoc. 2009;140(11):1377-1379.
6. Dell'Isola S, Ialungo AM, Starnini G, Roselli P, Ghittoni G, Caturelli E. A surprising hyperpigmentation of the gums and tongue. Gut. 2008;57(12):1697-1727.
7. Farshidi D, Chiu MW. Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C. J Am Acad Dermatol. 2010;62(1):164-165.
8. Fernández A, Vázquez S, Rodríguez-González L. Tongue hyperpigmentation resulting from peginterferon alpha-2a and ribavirin treatment in a Caucasian patient with chronic hepatitis C. J Eur Acad Dermatol Venereol. 2008;22(11):1389-1391.
9. Ghosh S, Duseja A, Dhiman RK, Chawla YK. Tongue hyperpigmentation resulting from peginterferon alfa-2b and ribavirin treatment in a patient with chronic hepatitis C. Dig Dis Sci. 2012;57(3):820-821.
10. Gurguta C, Kauer C, Bergholz U, Formann E, Steindl-Munda P, Ferenci P. Tongue and skin hyperpigmentation during PEG-interferon-alpha/ribavirin therapy in darkskinned non-Caucasian patients with chronic hepatitis C. Am J Gastroenterol. 2006;101(1):197-198. (Pubitemid 43381730)
11. Karabay O, Goksugur N, Ogutlu A. Tongue hyperpigmentation during interferon therapy. J Dermatol. 2011;38(3):290-291.
12. Lin J, Lott JP, Amorosa VK, Kovarik CL. Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin. J Am Acad Dermatol. 2009;60(5):882-883.
13. Sood A, Midha V, Bansal M, Goyal A, Sharma N. Lingual hyperpigmentation with pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. Indian J Gastroenterol. 2006;25(6):324. (Pubitemid 46708845)
14. Torres HA, Bull L, Arduino RC, Barnett BJ. Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy. Am J Gastroenterol. 2007;102(6):1334-1335. (Pubitemid 46802016)
15. Kameyama K, Tanaka S, Ishida Y, Hearing VJ. Interferons modulate the expression of hormone receptors on the surface of murine melanoma cells. J Clin Invest. 1989;83(1):213-221. (Pubitemid 19048426)